For research and educational purposes only. Not medical advice.
Cortexin Reference
Educational, not medical advice reference for Cortexin: Cognitive, Longevity; regulatory status, evidence posture, source review, and schedule notes. Also kn…
Reference summary
Russian-language randomized trial literature exists, primarily in stroke, TBI, and pediatric cognitive disorders. Publication quality and generalizability outside Russia / CIS regulatory frameworks are debated.
- Categories
- Cognitive, Longevity
- Aliases
- Bovine cortical neuropeptide preparation
- Evidence posture
- translational — Approved in Russia / CIS but not FDA-approved. Trial quality and generalizability outside the Russian regulatory framework are debated. No validated Western community protocol exists.
- Regulatory status
- No FDA-approved Cortexin drug label. Cortexin is a low-molecular-weight neuropeptide preparation derived from bovine cerebral cortex, approved in the Russian Federation and several CIS countries for stroke, traumatic brain injury, encephalopathy, and learning / memory indications. It is not FDA-approved.
- Content review status
- research reference